1183 related articles for article (PubMed ID: 21762134)
1. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
3. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
[TBL] [Abstract][Full Text] [Related]
4. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
[TBL] [Abstract][Full Text] [Related]
5. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS).
Blumenfeld AM; Varon SF; Wilcox TK; Buse DC; Kawata AK; Manack A; Goadsby PJ; Lipton RB
Cephalalgia; 2011 Feb; 31(3):301-15. PubMed ID: 20813784
[TBL] [Abstract][Full Text] [Related]
6. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
7. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.
Insinga RP; Ng-Mak DS; Hanson ME
Cephalalgia; 2011 Nov; 31(15):1570-5. PubMed ID: 22013140
[TBL] [Abstract][Full Text] [Related]
9. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial.
Lambert J; Carides GW; Meloche JP; Gerth WC; Marentette MA
Can J Clin Pharmacol; 2002; 9(3):158-64. PubMed ID: 12422253
[TBL] [Abstract][Full Text] [Related]
10. Examining the utility of in-clinic "rescue" therapy for acute migraine.
Morey V; Rothrock JF
Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
[TBL] [Abstract][Full Text] [Related]
11. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Bigal ME; Serrano D; Reed M; Lipton RB
Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
[TBL] [Abstract][Full Text] [Related]
12. The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics.
Payne KA; Varon SF; Kawata AK; Yeomans K; Wilcox TK; Manack A; Buse DC; Lipton RB; Goadsby PJ; Blumenfeld AM
Cephalalgia; 2011 Jul; 31(10):1116-30. PubMed ID: 21690175
[TBL] [Abstract][Full Text] [Related]
13. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).
Bloudek LM; Stokes M; Buse DC; Wilcox TK; Lipton RB; Goadsby PJ; Varon SF; Blumenfeld AM; Katsarava Z; Pascual J; Lanteri-Minet M; Cortelli P; Martelletti P
J Headache Pain; 2012 Jul; 13(5):361-78. PubMed ID: 22644214
[TBL] [Abstract][Full Text] [Related]
14. A retrospective matched case-control study on medical costs of refractory migraine in Taiwan.
Tang CH; Chen YC; Ng K; Wang SJ
Headache; 2013 Mar; 53(3):526-39. PubMed ID: 23406446
[TBL] [Abstract][Full Text] [Related]
15. Opioid use and dependence among persons with migraine: results of the AMPP study.
Buse DC; Pearlman SH; Reed ML; Serrano D; Ng-Mak DS; Lipton RB
Headache; 2012 Jan; 52(1):18-36. PubMed ID: 22268775
[TBL] [Abstract][Full Text] [Related]
16. Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Serrano D; Manack AN; Reed ML; Buse DC; Varon SF; Lipton RB
Value Health; 2013; 16(1):31-8. PubMed ID: 23337213
[TBL] [Abstract][Full Text] [Related]
17. Direct cost burden among insured US employees with migraine.
Hawkins K; Wang S; Rupnow M
Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
19. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
[TBL] [Abstract][Full Text] [Related]
20. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
